Early Host Responses During Co-Infection of Tick-Borne Pathogens

Information

  • Research Project
  • 10206023
  • ApplicationId
    10206023
  • Core Project Number
    R21AI146381
  • Full Project Number
    5R21AI146381-02
  • Serial Number
    146381
  • FOA Number
    PA-19-053
  • Sub Project Id
  • Project Start Date
    6/30/2020 - 4 years ago
  • Project End Date
    5/31/2022 - 2 years ago
  • Program Officer Name
    ILIAS, MALIHA R
  • Budget Start Date
    6/1/2021 - 3 years ago
  • Budget End Date
    5/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    5/11/2021 - 3 years ago
Organizations

Early Host Responses During Co-Infection of Tick-Borne Pathogens

Summary. Lyme Disease cases have increased more than 200% in the last decade. Antibiotic therapy is often effective, though many patients experience long-lasting complications, and it is not yet known why some patients develop chronic arthritis and neurologic involvement. Borrelia burgdorferi senso lato, the agent that causes Lyme Disease, is carried by the tick vector Ixodes scapularis. In addition to transmitting Lyme Disease I. scapularis carries and transmits other microorganisms, including species of Ehrlichia, Babesia, Anaplasma, as well as viral pathogens. This is significant as patients with tick-borne co-infections often exhibit more severe symptoms. It is currently unclear how the host innate immune system handles multiple pathogen types simultaneously. We propose to examine the impact of early innate myeloid cells on control of B. burgdorferi in mice co-infected with pathogens that are also transmitted by I. scapularis. Based on preliminary data we hypothesize that co-infecting pathogens elicit myeloid responses that are not able to control B. burgdorferi infection and result in enhanced dissemination. This is important because preventing dissemination reduces the probability of developing chronic disease. Our preliminary data demonstrate reduced blood neutrophils and platelets in mice co-infected with both Bb and an intracellular organism Ehrlichia muris, relative to mice infected with B. burgdorferi alone. We propose two related, but independent aims. In Aim 1 we will investigate the specific role of neutropenia, induced by co-infection, on B. burgdorferi dissemination. In Aim 2 we address the impact of thrombocytopenia and platelets on B. burgdorferi dissemination. This proof-of-concept work will address how infection with one pathogen enhances the infection, and dissemination, of another pathogen during tick-borne co-infection. Enhanced dissemination and infection of such tissues as the brain and heart are critical early events that induce susceptibility to long term complications. Information learned from these studies will define mechanisms of host defense against tick-borne co-infection, and may ultimately lead to novel therapies to prevent B. burgdorferi dissemination, which will reduce long-term complications such as carditis and arthritis.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R21
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    158219
  • Indirect Cost Amount
    47250
  • Total Cost
    205469
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIAID:205469\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    III
  • Study Section Name
    Innate Immunity and Inflammation Study Section
  • Organization Name
    ALBANY MEDICAL COLLEGE
  • Organization Department
    MICROBIOLOGY/IMMUN/VIROLOGY
  • Organization DUNS
    190592162
  • Organization City
    ALBANY
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    122083479
  • Organization District
    UNITED STATES